跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
在 國立成功大學 搜尋內容
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
查看斯高帕斯 (Scopus) 概要
張 勝勛
Doctor
外科部
電子郵件
chshen
mail.ncku.edu
tw
h-index
297
引文
8
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2003
2025
每年研究成果
概覽
指紋
網路
研究成果
(32)
類似的個人檔案
(6)
指紋
查看啟用 Shen-Shun Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Kidney Graft
100%
Living Donor
100%
Allograft
75%
Nephrectomy
66%
Effective Kidney Plasma Flow
66%
Surgical Technique
55%
Renal Artery
44%
Kidney Transplantation
37%
Glomerular Filtration Rate
33%
Maxillary Artery
33%
Gunshot Injury
33%
Scoring System
33%
HLA Antibody
33%
Enzyme Linked Immunosorbent Assay
33%
Peritoneal Fibrosis
33%
Contraindication
33%
Computer Assisted Tomography
33%
Suturing
33%
Alternariosis
33%
Peliosis Hepatis
33%
Ascites
33%
Reticulin
33%
Liver Dysfunction
33%
Obturator Hernia
33%
Surgical Anastomosis
33%
Peroperative Complication
26%
Bleeding
24%
Bovine Serum Albumin
23%
Creatinine
22%
Kidney Function
22%
Artery Reconstruction
19%
Laparoscopic Surgery
16%
Hyperbilirubinemia
16%
Sinusoid
16%
Liver Graft
16%
Needle Biopsy
16%
Thrombosis
15%
Heart Muscle Ischemia
13%
Body Mass Index
12%
Necrosis
11%
Postoperative Complication
11%
Learning Curve
11%
Ischemia
11%
Body Surface
9%
Oral Bleeding
8%
Vascular Surgery
8%
Intestine Perforation
8%
Phaeohyphomycosis
8%
Keyphrases
EDNRB Gene
33%
Internal Maxillary Artery
33%
Collet-Sicard Syndrome
33%
Gunshot Wound
33%
Kidney Transplantation
33%
HLA Antibodies
33%
Enzyme-linked Immunosorbent Assay (ELISA)
33%
Encapsulating Peritoneal Sclerosis
33%
Obturator Hernia
33%
Cross-matching
33%
Antibody Analysis
33%
Recipient Outcomes
33%
Living Kidney Donor
33%
Donor Nephrectomy
33%
Macrophage Adhesion
33%
Renal Transplant
33%
Computed Tomography
33%
Renoprotective Effect
33%
Surgical Outcomes
33%
Cutaneous Alternariosis
33%
Graft Function
33%
Short-term Outcomes
33%
Kidney Transplant Recipients
33%
Living Donor Kidney Transplantation
33%
Computed Tomography Score
33%
Peliosis Hepatis
33%
Massive Ascites
33%
Effective Renal Plasma Flow
33%
Kidney Graft Survival
33%
Scoring System
33%
Isoagglutinin Titer
33%
Cellcept
33%
Cyclosporine
33%
Tacrolimus
33%
Myfortic
33%
Disease Prevention
22%
Centers for Disease Control
22%
Enterolysis
20%
Graft Survival
20%
Mycophenolic Acid Levels
20%
Lambda
16%
Reticulin
16%
Liver Transplantation
16%
Reticulin Fiber
16%
Last Resort
16%
Laparoscopy
16%
Guided Biopsy
16%
Centrilobular
16%
Multiple Nodules
16%
Offending Drugs
16%
Immunology and Microbiology
HLA Antibody
66%
Reperfusion
66%
Severe Acute Respiratory Syndrome Coronavirus 2
66%
Spike
42%
Enzyme-Linked Immunosorbent Assay
41%
Kidney Transplantation
40%
Humoral Immunity
33%
Everolimus
33%
Fibronectin
33%
Effective Kidney Plasma Flow
33%
Macrophage
33%
Bovine Serum Albumin
23%
Glomerulus Filtration
19%
Immunosuppressive Drug
16%
Immune Response
16%
Myeloperoxidase
13%
Cold Ischemia
13%
Cell Migration
13%
CCAAT Enhancer Binding Protein Delta
13%
Receptor Binding
13%
Plasmapheresis
12%
Cytokine Release
11%
Hospital Mortality
11%
Surface Area
9%
Body Surface
9%
Kidney Function
9%
Peptides
9%
High Risk Population
8%
COVID-19
8%
Protein Microarray
8%
Comorbidity
8%
Extracellular Matrix
6%
Glomerulus
6%
Cell Adhesion
6%
Immunocompetent Cell
6%
Chemokine
6%
Cell Motility
6%
Inflammatory Cytokine
6%
Leukocyte
6%
Wild Type Mouse
6%
Cell Growth
6%
